Search

Your search keyword '"Krzych-Fałta, E"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Krzych-Fałta, E" Remove constraint Author: "Krzych-Fałta, E"
122 results on '"Krzych-Fałta, E"'

Search Results

3. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

5. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA‐ARIA) ‐ EIP on AHA Twinning Reference Site (GARD research demonstration project)

6. Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

7. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

8. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

9. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

10. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

11. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

12. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

13. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

14. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

15. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

16. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

17. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

18. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

19. Geolocation with respect to personal privacy for the Allergy Diary app - A MASK study

20. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

21. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

22. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly ( MACVIA ‐ ARIA ) ‐ EIP on AHA Twinning Reference Site ( GARD research demonstration project)

23. The Safety of Nasal Allergen Challenge Test Assessed in Lower Airways

24. Development of senioral policy in Poland – analysis

26. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

30. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

31. Attitudes towards Maternal Immunisation of Polish Mothers: A Cross-Sectional, Non-Representative Study.

32. Co-occurrence of otitis media with effusion and another environment-dependent disease (selected allergic conditions).

33. Measuring the Intensity of Stress Experienced and Its Impact on Life in Patients with Diagnosed Alcohol Use Disorder.

34. Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.

35. Differential diagnostics of food allergy as based on provocation tests and laboratory diagnostic assays.

36. The importance of specific IgE antibodies in the epidemiology of allergic rhinitis and asthma (ECAP survey): part four. The relationship between the concentration of specific IgE antibodies in serum and types of asthma.

37. The importance of specific IgE antibodies in the epidemiology of allergic rhinitis and asthma (ECAP survey): part five. The relationship between the concentration of specific IgE antibodies in serum and types of rhinitis.

38. Why the role of mHealth in allergy diagnosis and treatment adherence cannot be overlooked.

39. Management of Metastatic Pancreatic Cancer-Comparison of Global Guidelines over the Last 5 Years.

40. Methodological Principles of Nasal Food Challenge.

41. Evaluation of Health Pattern and Stress Levels among Patients Undergoing Alcohol Addiction Treatment-A Cross Sectional Study.

42. Acceptance of Illness and Coping with Stress among Patients Undergoing Alcohol Addiction Therapy.

43. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations.

44. Treatment Costs and Social Burden of Pancreatic Cancer.

45. Quality of Life in Patients with Pancreatic Cancer-A Literature Review.

46. Evaluation of selected aspects of the hygiene hypothesis and their effect on the incidence of allergy.

47. The increase in allergic conditions based on a review of literature.

48. Reactivity of nasal cavity mucosa in the nasal cow's milk allergen provocation test.

49. Nasal lavage fluid sIgE levels in differential diagnostics of allergic rhinitis.

50. Influence of Selected Indicators of Healthcare System Functioning Evaluation on the Health Result.

Catalog

Books, media, physical & digital resources